NeuroNEXT News

NeuroNEXT 2019 Annual Meeting Slides Available

The slide presentation from the 2019 NeuroNEXT Annual Meeting in Pittsburgh, PA October 28-29 are now available on the NeuroNEXT private website. They can be accessed under Network Materials > Annual Meetings. Thanks to everyone for a successful meeting!

TRANSCENDS Program Application Cycle: July 15-October 15, 2019

External Source: 

The AAN is collaborating with the Medical University of South Carolina (MUSC) to offer The TRANSCENDS (Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars) Scholars program. This program is funded by a NINDS R25. The TRANSCENDS program is designed to train promising early-career neurologists to conduct high-quality neurologic research and achieve a successful academic career. 

Program Details

NIH soliciting for Pain Research Centers: Applications due June 3rd!

External Source: 

NIH is soliciting for Pain Research Centers to join a clinical trial network.  NIH has mounted a major effort to improve pain management as a part of its response to the opioid crisis in America.  One cornerstone of that effort is an phase 2 clinical trial network to test new, non-addictive pain therapies in well-phenotyped patients.  This is part of a public-private partnership with academia, pharmaceutical companies, biotechnology and device companies.

NeuroNEXT Annual Meeting Slides Available

The slide presentation from the 2018 NeuroNEXT Annual Meeting in Boston, MA October 18-19 are now available on the NeuroNEXT private website. They can be accessed under Network Materials > Annual Meetings. Thanks to everyone for a successful meeting!

NeuroNEXT at the University of Iowa

The University of Iowa highlighted NeuroNEXT achievements in two campus publications: Iowa Now provides an overview of the ways the Network is accelerating the clinical trials process, and The Daily Iowan focuses on the ways NeuroNEXT is bringing together clinical sites and coordinating centers to advance neurological trials.